Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype

This publication has 16 references indexed in Scilit:

• Genetic association between sensitivity to warfarin and expression of CYP2C9*3
  Pharmacogenetics, 1997
• The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
  Pharmacogenetics, 1997
• Genetic analysis of the human cytochrome P450 CYP2C9 locus
  Pharmacogenetics, 1996
• Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms
  Archives of Biochemistry and Biophysics, 1996
• The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
  Pharmacogenetics, 1996
• Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
  Pharmacogenetics, 1995
• Oral Anticoagulant Therapy—50 Years Later
  Archives of internal medicine (1960), 1993
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
  Chemical Research in Toxicology, 1992
• Genetic polymorphism of S-mephenytoin hydroxylation
  Pharmacology & Therapeutics, 1989
• A comparison of the isomers of warfarin
  Biochemical Pharmacology, 1966